Latest news
Why Revolution Medicines (RVMD) Is Up 9.4% After Mounting Losses And Surging Daraxonrasib Demand – And What's Next - simplywall.stsimplywall.st · Sat, 08 Aug 2026 19:45:53 GMTHere’s How Much You Would Have Made Owning Revolution Medicines Stock In The Last 5 Years - BenzingaBenzinga · Fri, 07 Aug 2026 23:30:37 GMT'We're excited and ready to go': Fast-growing Revolution Medicines preps potential launch of blockbuster pancreatic cancer drug - The Business JournalsThe Business Journals · Fri, 07 Aug 2026 13:29:00 GMTHigh Risk, High Reward: Inside The Revolution Medicines Bull Case (NASDAQ:RVMD) - Seeking AlphaSeeking Alpha · Fri, 07 Aug 2026 08:19:34 GMTOppenheimer Adjusts PT on Revolution Medicines to $230 From $195, Maintains Outperform Rating - MoomooMoomoo · Thu, 06 Aug 2026 18:45:11 GMTRevolution Medicines, Inc. Stock 12‑Month Price Target Raised to $216.4, Implies 10% Upside - TradingViewTradingView · Thu, 06 Aug 2026 17:20:26 GMTQuantinno Capital Management LP Boosts Stake in Revolution Medicines, Inc. $RVMD - MarketBeatMarketBeat · Thu, 06 Aug 2026 08:47:33 GMTRevolution Medicines Q2 Earnings Call Highlights - MarketBeatMarketBeat · Thu, 06 Aug 2026 04:08:24 GMT